Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TIFFANY NORTON

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1629641139
CMS profile
10894178
Location
MADISONVILLE, TN

General Payments · PY2021–2024

$777.78

  • Reported across 49 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$264.73

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $264.73 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $74.87 4
ITI, Inc. $71.40 4
Xeris Pharmaceuticals, Inc. $28.62 2
PFIZER INC. $27.47 2
ABBVIE INC. $22.86 1
Otsuka America Pharmaceutical, Inc. $21.86 1
DEXCOM, INC. $17.65 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $62.42 4
PY2022 $136.04 9
PY2023 $314.59 21
PY2024 $264.73 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.86 03/28/2024 Food and Beverage Undisputed 01/23/2026 1107746593 CMS
Dexcom, Inc. $17.65 12/05/2024 Food and Beverage Undisputed 01/23/2026 1153389758 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.07 08/20/2024 Food and Beverage Undisputed 01/23/2026 1143571540 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.79 10/22/2024 Food and Beverage Undisputed 01/23/2026 1143571542 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.29 11/18/2024 Food and Beverage Undisputed 01/23/2026 1143571544 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.25 12/09/2024 Food and Beverage Undisputed 01/23/2026 1143571546 CMS
Novo Nordisk Inc $18.15 02/06/2024 Food and Beverage Undisputed 01/23/2026 1100493307 CMS
Novo Nordisk Inc $17.79 03/18/2024 Food and Beverage Undisputed 01/23/2026 1100548622 CMS
Novo Nordisk Inc $19.38 06/20/2024 Food and Beverage Undisputed 01/23/2026 1100457510 CMS
Novo Nordisk Inc $19.55 09/18/2024 Food and Beverage Undisputed 01/23/2026 1100356168 CMS
Otsuka America Pharmaceutical, Inc. $21.86 10/29/2024 Food and Beverage Undisputed 01/23/2026 1119150788 CMS
PFIZER INC. $13.20 05/13/2024 Food and Beverage Undisputed 01/23/2026 1132032931 CMS
PFIZER INC. $14.27 11/13/2024 Food and Beverage Undisputed 01/23/2026 1131277921 CMS
Xeris Pharmaceuticals, Inc. $13.83 01/08/2024 Food and Beverage Undisputed 01/23/2026 1144640122 CMS
Xeris Pharmaceuticals, Inc. $14.79 03/19/2024 Food and Beverage Undisputed 01/23/2026 1144640124 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.